MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/1060028018803587

Медицинская библиотека · The Annals of pharmacotherapy · 2018

Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy.

Fogueri Uma, Cheungapasitporn Wisit, Bourne David, Fervenza Fernando C, Joy Melanie S

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Rituximab (RTX) is a chimeric monoclonal anti-CD20 antibody used off-label in the treatment of membranous nephropathy (MN). Unfortunately, limited information is available on the pharmacokinetics of therapeutic proteins such as RTX in patients with glomerular kidney diseases.

OBJECTIVE

The current study evaluated RTX pharmacokinetics in patients with MN (n = 20) who received 4 RTX weekly intravenous infusions (375 mg/m2) over a month, with a repeat of the identical treatment at 6 months. Baseline patient characteristics were gender (17 male/3 female), age (49 ± 13 years), and body surface area (2.2 ± 0.24 m2).

METHODS

Compartmental pharmacokinetic analyses were conducted using Phoenix, and comparisons of these parameters were made between the MN patients and published data from 2 reference populations without kidney diseases (follicular lymphoma and autoimmune disorders).

RESULTS

Patients with MN exhibited a shorter half-life, reduced volume of central compartment, decreased area under the serum concentration-time curve (exposure), and increased RTX clearance from the central compartment versus previous reports in the reference patient populations.

CONCLUSIONS AND RELEVANCE: These results suggest that shorter half-life and lower exposures to RTX in patients with MN may necessitate higher doses and/or changes to dosing frequency to optimize the relationships between serum concentrations and therapeutic effects.

Для цитирования: Fogueri Uma, Cheungapasitporn Wisit, Bourne David, Fervenza Fernando C, Joy Melanie S. Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy.. The Annals of pharmacotherapy. 2018. DOI: 10.1177/1060028018803587.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.